Creative Touch Permanent Makeup and Aesthetics

All skin ages through three converging dermal mechanisms: net collagen loss (declining fibroblast synthesis against rising MMP-driven degradation), elastic fibre fragmentation ( MMP-12 elastase activity and solar elastosis accumulation), and ground substance depletion (declining hyaluronic acid and proteoglycan content reducing the mechanical tension environment fibroblasts require). These operate in all skin from the mid-20s onwards, but the rate at which they become clinically visible varies enormously depending on UV history, hormonal context, glycation load, cortisol environment, and individual genetic variation. UV radiation alone accounts for approximately 80% of visible facial ageing, meaning that most of what presents as structural skin decline in clinic is not simply time – it is time compounded by cumulative photodamage. Understanding which mechanisms are dominant in a given presentation is what determines whether the treatment priority is anti-degradation, pro-synthesis, barrier restoration, or structural volume replacement. Skin, however, is only the outermost layer of a three-dimensional ageing process: beneath it, the fat compartments, mimetic muscles, and facial skeleton are simultaneously changing – and it is the interplay between skeletal bone loss, fat descent, and muscular repositioning that ultimately determines what the skin’s surface looks like, and which interventions can most effectively restore it.

Intrinsic Ageing: The Baseline Decline

Intrinsic or chronological ageing is the irreducible biological minimum – the rate at which skin structure declines in the complete absence of environmental exposure. It affects all skin, including sun-protected sites, and is driven by the accumulating cellular changes of time: fibroblast TGF-β1 decline, telomere shortening reducing proliferative capacity, increasing ROS load from mitochondrial inefficiency, and progressive fibroblast senescence accumulation. ^[1] The aggregate output of these processes – chronic low-level sterile inflammation driven by SASP-secreting senescent cells, mitochondrial DNA leakage activating cGAS-STING, and self-amplifying NF-κB activity – is the biological state described as inflammageing, covered in its own entity. Intrinsic ageing and inflammageing are not separate processes; inflammageing is the inflammatory dimension of intrinsic ageing, and understanding it explains why structural decline is progressive and self-amplifying rather than simply linear.

The timeline of intrinsic collagen decline is well-characterised. Collagen production begins declining from approximately the mid-20s, falling at roughly 1–1.5% per year from the third decade onwards. ^[9] The clinical consequences of this rate accumulate slowly: a 1% annual loss is imperceptible year-to-year but represents a 20–25% reduction by the mid-40s. The visible manifestations of intrinsic ageing – fine surface lines, gradual loss of structural firmness, mild textural change – typically become apparent in the 40s and 50s, when the cumulative deficit passes a clinical visibility threshold.

Intrinsic ageing is modulated by sex. Men carry approximately 25% thicker skin than women at baseline, with higher collagen density at every age. Male skin thickness declines linearly from approximately age 20 – a slow and consistent trajectory. Women’s skin thickness tends to remain relatively stable until approximately age 50, at which point the hormonal withdrawal of menopause creates a sharp acceleration. ^[6] The practical consequence is that women often experience their most rapid structural skin change in a compressed window at and around menopause – what has been a gradual background process suddenly accelerates, which is frequently experienced as the skin changing abruptly rather than progressively. Men age more consistently but are not protected: by the late 50s and 60s, the cumulative deficit from three to four decades of linear decline is substantial, typically presenting as deep expression lines, significant laxity in the lower face, and a loss of structural density that developed without a clear accelerating event.

Extrinsic Ageing: UV as the Primary Driver

Extrinsic ageing is primarily UV-driven – UV radiation accounts for approximately 80% of visible facial skin ageing, making it by some margin the most significant modifiable factor in how skin presents relative to chronological age. ^[9] UV acts through three converging mechanisms that overlap completely with intrinsic decline but operate faster and more aggressively:

MMP upregulation: UV radiation activates AP-1 transcription factors in both keratinocytes and fibroblasts, driving expression of MMP-1, MMP-3, and MMP-9 – the collagenase, stromelysin, and gelatinase enzymes that degrade Type I and III collagen and the fibronectin and laminin of the ECM. Each UV exposure produces a pulse of MMP activity that degrades a fraction of the existing collagen matrix; repeated over years, this cumulative MMP burden produces the characteristic accelerated collagen fragmentation of photoaged skin.

Solar elastosis: Chronic UV exposure drives abnormal accumulation of dysfunctional elastin-like material in the upper and mid- dermis – the amorphous solar elastotic deposits that replace normal organised elastic fibre networks in photoaged skin. Unlike normal elastic fibres, elastotic material has no stretch-and-recoil capacity and physically obstructs the assembly of new functional fibres.

Collagen VII degradation at the DEJ: UV-driven MMP activity specifically degrades Type VII collagen – the anchoring fibril protein of the dermo-epidermal junction. Its progressive loss weakens the mechanical connection between epidermis and dermis, contributing to the crepey fragility characteristic of heavily photoaged skin. ^[9]

UV radiation is also the single largest modifiable accelerator of skin-specific inflammageing – generating DAMPs through direct DNA damage, inducing keratinocyte and fibroblast senescence, and activating NF-κB through multiple parallel pathways. The structural collagen and elastin consequences described here are the downstream tissue-level output of those cellular events; the full molecular mechanism is covered in the Inflammageing entity.

Other extrinsic factors – smoking, air pollution, chronic sleep deprivation, high glycaemic dietary patterns – each accelerate specific aspects of the same mechanisms. Smoking generates ROS that upregulate MMP activity and impair collagen synthesis independently of UV. Pollution particulates penetrate the stratum corneum and generate intracellular oxidative stress in keratinocytes and fibroblasts. Dietary glycation from high blood sugar creates AGE crosslinks on collagen and elastin, stiffening and disorganising the matrix through a mechanism entirely distinct from MMP degradation. Each accelerant compounds the intrinsic baseline; none of them is required for ageing to occur, but all of them accelerate it.

The Compounding Logic

The reason skin ageing does not look like a simple linear function of time is that its underlying mechanisms compound rather than add. A fibroblast population experiencing reduced TGF-β1 drive, accumulating senescent cells with pro-inflammatory SASP output, operating in a UV-degraded ECM with reduced mechanical tension, and metabolising procollagen in a vitamin C-compromised hydroxylation environment is not simply experiencing four separate problems. The senescent fibroblasts’ MMP secretion degrades the ECM that provides mechanosensory input to functional fibroblasts, reducing their synthesis output – so senescence causes mechanosensory collapse as a downstream consequence. The degraded ECM reduces decorin content, allowing newly synthesised collagen fibrils to organise poorly – so the quality of new synthesis is reduced even when quantity is maintained. The solar elastosis accumulation blocks new elastic fibre assembly, meaning any elastin synthesis is less productive regardless of the signal driving it.

This is why the clinical presentation in a 55-year-old with significant UV history is not simply three times the presentation of a 35-year-old with the same history. The mechanisms have been compounding, each decline making the others worse, for decades. It is also why protocols addressing only one mechanism produce limited outcomes: stimulating collagen synthesis into a still-degraded ECM with still-elevated MMP activity, in a fibroblast population still receiving reduced mechanosensory input, produces results that are slower, less complete, and less durable than the same stimulus into a recovered environment.

At the molecular level, what connects these structural compounding mechanisms is NF-κB – the transcription factor chronically activated by SASP cytokines, ROS, and DAMP signalling in ageing tissue. NF-κB drives both MMP expression and further SASP production, meaning the inflammatory amplification loop and the structural compounding loop are not parallel processes: they are the same process operating at different scales of biological organisation simultaneously.

Individual Variation: Why Two People of the Same Age Look Different

The most clinically useful insight from the ageing biology for client conversations is understanding why intrinsic age and visible age diverge so substantially between individuals. The primary variables:

• UV history: the single largest determinant of visible ageing rate; a consistent 30+ SPF from the 20s onwards demonstrably shifts visible ageing forward by years relative to comparable sun-exposed peers

• Hormonal context: women without significant UV history show relatively well-preserved skin until the menopausal transition, at which point the compounding of chronological decline with hormonal withdrawal produces rapid change; men age more consistently but carry no equivalent hormonal protection earlier in life

• Glycation load: determined by dietary glycaemic patterns over decades; AGE crosslinks on collagen accumulate progressively and are largely irreversible, creating a structural stiffening that is independent of MMP degradation and does not respond to collagen-stimulating treatments

• Cortisol environment: chronic stress and age-related 11β-HSD1 upregulation both suppress fibroblast collagen output and impair barrier recovery; clients with long stress histories or significant sleep disruption over years carry an accelerated collagen deficit independent of UV. Mechanistically, sustained cortisol elevation promotes NF-κB activity and accelerates telomere shortening – connecting psychological stress history directly to the inflammageing trajectory rather than simply to fibroblast collagen output in isolation.

• Genetic baseline: collagen density, fibroblast longevity, and MMP regulation all have heritable components that determine the starting point from which environmental and hormonal factors operate

The Four-Layer Cascade: Facial Ageing Beyond the Skin

Skin biology explains what happens to the tissue itself – but not why a face changes shape as it ages. The structural remodelling visible as facial volume loss, descent, and altered proportions is the product of simultaneous change across four tissue layers: the skeleton, the subcutaneous fat compartments, the mimetic muscles, and the skin surface. These layers are mechanically interdependent, and what happens in the deeper layers propagates upward to determine what the skin’s surface ultimately presents as.

The skeletal foundation. The facial skeleton is not static. Three-dimensional computed tomographic studies have established that specific regions of the craniofacial skeleton undergo measurable resorption with age – the midface and maxilla, the orbital rim, and the prejowl mandible are particularly affected, with clinical implications for soft tissue support reviewed in detail by Mendelson and Wong (2012). ^[2] The orbital aperture expands, the pyriform (nasal) aperture widens, and mandibular height and body length decrease – changes quantified across large cohorts of adult subjects using CT volumetric analysis. ^[5] The practical consequence is loss of scaffolding: the bony projections and angles that hold soft tissue in a youthful three-dimensional position gradually recede, and overlying tissue loses its structural support.

Fat compartment changes. The subcutaneous fat of the face is not a uniform layer. Cadaveric anatomy studies have established it as a series of discrete, anatomically bounded compartments – nasolabial, medial cheek, middle cheek, lateral temporal cheek, and orbital zones, among others – each with its own blood supply and each ageing independently. ^[4] With age, deep fat compartments typically undergo greater volume loss than superficial ones, ^[3] whilst superficial compartments descend as the ligamentous structures holding them in place progressively relax. ^[8] The result is not simple deflation but repositioning: what appears as hollowing in one region and heaviness in another often reflects the same process – downward migration of compartments that once sat higher on the face.

Muscular and surface consequences. Mimetic muscle position shifts as skeletal support recedes and ligament laxity increases. The skin surface – already contending with intrinsic and extrinsic dermal ageing – reflects these deeper changes as well as its own: nasolabial fold deepening, jowl formation, and lid-cheek junction descent are surface expressions of the deeper four-layer cascade working in concert. Quantitative three-dimensional facial analysis has shown that post-menopausal women experience an accelerated shift in this cascade, with the pattern of facial shape change from age 50 onwards strongly predicted by mandibular bone resorption specifically. ^[7] This suggests hormonal decline may accelerate the skeletal contribution to surface change, providing a plausible connection between the endocrine mechanisms discussed earlier in this entry and the structural cascade.

Understanding this layered architecture is what underpins treatment decisions that go beyond the skin. Restoring dermal collagen is important, but if the skeletal foundation has receded and the fat compartments have descended, the skin is now draping differently over a changed substructure. Volumetric treatments – hyaluronic acid fillers, biostimulators such as PLLA, and structured injection protocols – work partly because they address this deeper layer, not only the dermis itself.